1AI 10.0% 0.9¢ algorae pharmaceuticals limited

Ann: Results of LCT Parkinsons trial require further analysis, page-44

  1. 16,651 Posts.
    lightbulb Created with Sketch. 2375
    I've pointed out all the potential mitigation - the potential for patient characteristics to have masked efficacy of a subgroup, or evaluating the patients to early.

    But no, I'm not buying until I see the further analysis and their back up plan. Or unless Diabecell has some progress.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.9¢
Change
-0.001(10.0%)
Mkt cap ! $15.18M
Open High Low Value Volume
0.9¢ 0.9¢ 0.9¢ $750 83.33K

Buyers (Bids)

No. Vol. Price($)
5 206531 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 383746 1
View Market Depth
Last trade - 14.28pm 12/07/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.